2020 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸ : 2020-03-21 |
|
2020 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸ : 2020-03-21 ±³À°ÀÏÀÚ : 2020-03-21 ±³À°Àå¼Ò : ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°´ç ±³À°ÁÖÁ¦ : 2020 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇÑÄ¡¸ÅÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ ´ã´çÀÚ : ÀÌÀºÁö ¿¬¶ôó : 055-270-1587 À̸ÞÀÏ : namu1415@naver.com ±³À°Á¾·ù : ½Å°æ°ú Âü¼®¿¹»óÀοø : 100¸í Èñ¸ÁÆòÁ¡ : 3Á¡ Áö¿ª : ºÎ»ê±¤¿ª½Ã ±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ ¼¼ºÎ¼ö°·á : 20,000¿ø ºñ°í »çÀüµî·Ï 10,000¿ø / ÇöÀåµî·Ï 20,000¿ø ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±âŸ 03-21 ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°´ç 14:00~14:30 µî·Ï () ±âŸ 03-21 ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°´ç 14:30~14:40 Àλ縻 ±ÇÀçö(â¿øÆÄƼ¸¶º´¿ø) ±³À°½Ã°£ 03-21 ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°´ç 14:40~15:15 AD Pathophysiology-Amyloid to Tau ¹ÚÀ±¾Æ(°í½Å´ëÇб³º´¿ø) ±³À°½Ã°£ 03-21 ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°´ç 15:15~15:50 Amyloid Hypothsis-pros and cons: Pros ¼»ó¿ø(»ï¼º¼¿ïº´¿ø) ±³À°½Ã°£ 03-21 ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°´ç 15:50~16:25 Amyloid Hypothsis-pros and cons: Cons ½É¿ë¼ö(°¡Å縯´ëÇб³ ¼º¸ðº´¿ø) ÈÞ½Ä 03-21 ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°´ç 16:25~16:45 Coffee Break () ±³À°½Ã°£ 03-21 ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°´ç 16:45~17:25 Cognitive reserve and dementia, clinical perspective ±è»óÀ±(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç & ºÐ´ç¼¿ï´ëÇб³º´¿ø ³ú½Å°æ¼¾ÅÍ) ±³À°½Ã°£ 03-21 ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°´ç 17:25~18:00 Cognitive reserve and dementia, neuroimaging perspective ¼ºÁØ°æ(°í·Á´ëÇб³) |
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|
Á¦¸ñ |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 454 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 811 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 532 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 473 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 608 , ´ñ±Û¼ö : 0 |